October 10, 2019

Pharos – Participation in CPhI 2019

Pharos participated in the CPhI Worldwide exhibition, which this year took place in Frankfurt. CPhI has hosted more than 48,000 visiting pharma professionals over three days. […]
October 3, 2019

Diorama concluded its investment in PharOs

DECA Investments AIFM, the exclusive investment manager of Diorama Investments SICAR (“Diorama” or the “Fund”), announced the completion of the Fund’s ninth investment: the acquisition of […]
September 30, 2019

Minerva S.A. acquisition completed

ELAIA ZEUS S.A., a company controlled by the Investment Fund Diorama Investments Sicar S.A. in which also participates the investment Fund Elikonos 2 SCA Sicar, announces […]
February 19, 2019

GMP Certification for Pharos MT

Pharos received the GMP certification for the production facility of Pharos Malta (Pharos MT). Pharos MT’s facility is located in Hal Far manufacturing site and has […]